Navigation Links
MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
Date:8/6/2012

KENNESAW, Ga., Aug. 6, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company has raised over $4.9 million through the exercise of Callable Warrants issued in conjunction with the October 2010 Private Placement.

The Company exercised its right to redeem the Warrants effective August 3, 2012.  Holders had the option to exercise the Warrants or have them redeemed by the Company.  Over 98% of the Callable Warrants were exercised. 

Parker H. "Pete" Petit, Chairman and CEO, said, "The exercise of these Warrants is a 'win-win' for the Company and our investors, as it strengthens our balance sheet, and provides a nice return for the holders.  The Company intends to use the proceeds for general operating needs, including additional clinical trials, as well as the addition of some key direct sales force hires.  These hires will also help expedite our strategy to expand our direct sales representatives and move  toward a blended sales force."

Cancellation of Second Contingent Warrants

The Company also announced the cancellation of approximately 3.2 million Second Contingent Warrants.  The Warrants had been issued to holders that invested in the Company's October 2010 Private Placement and the Senior Secured Promissory Notes issued in December 2011.  More details regarding the terms of the private placement and warrants are disclosed in the Company's SEC filings.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal its
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
2. MiMedx Group Announces Record Second Quarter Results
3. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
4. MiMedx Group Announces Record First Quarter Results
5. MiMedx Exceeds Revenue Goal for First Quarter of 2012
6. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
7. MiMedx Group Announces 2011 Results
8. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
9. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
10. MiMedx Group Completes $5,000,000 Private Placement
11. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... key challenges in the development of quantum technologies has ... a paper published today (28 October) in Nature ... to make a new type of flexibly designed microscopic ... high-precision sensors and specialised superfast computers, often depend on ... for trapping these tiny particles are hugely problematic because ...
(Date:10/27/2014)... (PRWEB) October 27, 2014 The ... by Type (High & Medium), Sub-type (Primary & ... Processing, Infrastructure & Transportation & Power Generation) - ... the GIS market with analysis and forecasting of ... Market Data Tables with 52 Figures spread through ...
(Date:10/27/2014)... NEW YORK , Oct. 27, 2014 ... in the recent Ebola concern in the ... for the virus.  The healthcare market researcher said the ... of in vitro diagnostic tests for the detection of ... sensitivity has proved useful.  Kalorama routinely assess the IVD ...
(Date:10/27/2014)... Called the NOAH Protocol, this investigative ... of pediatric brain cancer. The implications for groundbreaking ... years of research and development. Amber Larkin, the ... mom's determination can make a difference. , ... it’s only fitting that we’ve received FDA approval ...
Breaking Biology Technology:Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3
... MANASQUAN, N.J., April 7, 2008 BioSpace, the ... career fair company,will host a Private Label Career ... The event will take place at the Hanover ... 7 pm., (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), ...
... to advance collaborative research worldwide, HUNTSVILLE, ... Inc.,announced today that leading research institutions, the ... the University of,Queensland, and the Biotech Research ... of Copenhagen have recently purchased access to ...
... found that the,Replikin Count(TM) of the H1N1 strain of ... highest level since the 1918 H1N1,pandemic (p value less ... strain, indicating rapid replication of the virus, is an ... of the specific,strain. The current increase appears to be ...
Cached Biology Technology:BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey 2Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 2Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 3H1N1 Influenza Virus With Highest Replikin Count(TM) Since the 1918 Pandemic Identified in the U.S. and Austria 2
(Date:10/29/2014)... Online registration is open for the ... Scientific Meeting. SIR 2015 is the one ... trainees and related health care professionals can ... image-guided science and technologies being presented, discussed ... community in minimally invasive, image-guided medicine, SIR ...
(Date:10/29/2014)... City on September 19, 2014, leading geneticist and humanitarian ... Genome Sciences and Medicine at the University of Washington ... Tel Aviv University, was awarded the 2014 Lasker-Koshland Special ... her honorary degree from TAU, Prof. King was the ... and for the past 18 years she has been ...
(Date:10/29/2014)... — Cambridge, MA and Hebei, China — BGI Tech ... quality sequencing of the Jujube genome. Jujube is the ... the Jujube genome is particularly difficult to sequence due ... It is the first time that a genome in ... has been recently published in Nature Communications ...
Breaking Biology News(10 mins):SIR 2015: Interventional radiology shapes tomorrow's medicine 2Geneticist and humanitarian: Prof. Mary-Claire King receives Lasker Award 2BGI Tech and Hebei Agricultural University complete the genome sequencing of the jujube tree 2
... 2013 Oxidative stress is a primary villain in ... heart failure to Alzheimer,s disease, Amyotrophic Lateral Sclerosis and ... The Scripps Research Institute (TSRI) have found that blocking ... destruction of neurons associated with these neurodegenerative diseases, suggesting ...
... biofuel crops such as miscanthus, whose high yields have ... corn in producing ethanol, are now shown to have ... nitrogen in the environment. In a 4-year University of ... species to typical corn-corn-soybean rotations, each of the perennial ...
... in the part of the brain linked to spatial awareness. ... room, we can go into it with our eyes shut and ... we map out how to get from one place to another ... in electrical activity, do not do so by talking directly to ...
Cached Biology News:Scripps Florida scientists uncover potential drug target to block cell death in Parkinson's disease 2Lower nitrogen losses with perennial biofuel crops 2Lower nitrogen losses with perennial biofuel crops 3Rhythms in the brain help give a sense of location, study shows 2